OK Biotech , Ltd. Profit Margin

OK Biotech , Ltd. (4155.TW) currently reports a profit margin of 15.76% as of June 2026. That compares with -2.37% in the prior-year period — up 765.7% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore OK Biotech , Ltd.'s profit margin history and peer comparisons.

OK Biotech , Ltd.'s profit margin increased from -2.37% to 15.76% — a 765.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OK Biotech , Ltd.'s profit margin of 15.76% is higher than the its sector sector average of 13.23%. That is roughly 19.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but OK Biotech , Ltd.'s current 15.76% should be judged against industry norms (sector average: 13.23%) and against 4155.TW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 15.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for OK Biotech , Ltd., and consider following 4155.TW for alerts when major investors trade the stock.